Axokine


Also found in: Wikipedia.

Axokine®

Ciliary neurotrophic factor, see there.
References in periodicals archive ?
Rimonabant and Regeneron Pharmaceuticals' injectable Axokine were both briefly discussed, as both have recently completed last-stage testing, Axokine helped patients lose 3.
One of those drugs, Axokine, recently received fast-track approval status from the Food and Drug Administration--a first for an obesity drug.
Its Axokine drug is currently undergoing Phase III trials, and if granted full Food & Drug Administration approval, promises to be a major boost to both the industry and company.
But a pegylated version of Axokine that is now under study would work longer and require less frequent administration.
However, we are guarded with respect to Axokine, a candidate for the treatment of obesity, which may produce additional near-term volatility.
This decline in expenses for the AXOKINE and IL-1 Trap programs was partially offset by increased VEGF Trap development expenses, which are being fully funded by Aventis.
The Complaint alleges that defendants issued a series of materially false and misleading statements concerning the Company's weight loss drug AXOKINE and its effectiveness in treating obese patients.
AXOKINE is in Phase III trials for the treatment of obesity.
During the Class Period, Regeneron initiated and completed Phase II and Phase III clinical studies of its drug AXOKINE for the treatment of obesity.
Along with that announcement, the company decided to pursue another Axokine study in obese type 2 diabetic patients, which Nadine Wong believes will decide the true worth of this therapy.
Food and Drug Administration (FDA) to review results from the initial pivotal trial completed earlier this year and the Company's plans for future development of AXOKINE.